Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:40 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | EVENTIDE ASSET MANAGEMENT LLC | 3,626,508 7.600% | 776,508 (+27.25%) | Filing History |
| 2023-02-14 1:38 pm Sale | 2022-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | EVENTIDE ASSET MANAGEMENT LLC | 234,537 7.500% | -19,503 (-7.68%) | Filing History |
| 2023-02-14 1:36 pm Sale | 2022-12-31 | 13G | KNOWBE4 INC CLASS A KNBE | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,177,983 (Position Closed) | Filing History |
| 2023-02-14 1:34 pm Purchase | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,057,000 5.600% | 2,057,000 (New Position) | Filing History |
| 2023-02-14 1:32 pm Purchase | 2022-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 3,150,000 6.600% | 3,150,000 (New Position) | Filing History |
| 2023-02-14 1:30 pm Purchase | 2022-12-31 | 13G | AURA BIOSCIENCES INC AURA | EVENTIDE ASSET MANAGEMENT LLC | 2,251,368 6.300% | 2,251,368 (New Position) | Filing History |
| 2023-02-14 1:24 pm Purchase | 2022-12-31 | 13G | 908 DEVICES INC MASS | EVENTIDE ASSET MANAGEMENT LLC | 2,230,665 7.000% | 2,230,665 (New Position) | Filing History |
| 2022-02-14 12:04 pm Purchase | 2021-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | EVENTIDE ASSET MANAGEMENT LLC | 2,629,593 7.600% | 201,617 (+8.30%) | Filing History |
| 2022-02-14 12:01 pm Purchase | 2021-12-31 | 13G | VITAL FARMS INC VITL | EVENTIDE ASSET MANAGEMENT LLC | 2,950,000 7.300% | 896,768 (+43.68%) | Filing History |
| 2022-02-14 12:00 pm Purchase | 2021-12-31 | 13G | SUTRO BIOPHARMA INC STRO | EVENTIDE ASSET MANAGEMENT LLC | 270,898 5.900% | 33,800 (+14.26%) | Filing History |
| 2022-02-14 11:57 am Purchase | 2021-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | EVENTIDE ASSET MANAGEMENT LLC | 254,040 8.500% | 19,835 (+8.47%) | Filing History |
| 2022-02-14 11:55 am Sale | 2021-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | EVENTIDE ASSET MANAGEMENT LLC | 42,499 0.100% | -2,795,626 (-98.50%) | Filing History |
| 2022-02-14 11:53 am Sale | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | EVENTIDE ASSET MANAGEMENT LLC | 138,821 0.600% | -1,541,179 (-91.74%) | Filing History |
| 2022-02-14 11:50 am Sale | 2021-12-31 | 13G | KALA PHARMACEUTICALS INC KALA | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -138,000 (Position Closed) | Filing History |
| 2022-02-14 11:47 am Purchase | 2021-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | EVENTIDE ASSET MANAGEMENT LLC | 232,377 9.700% | 66,667 (+40.23%) | Filing History |
| 2022-02-14 11:46 am Purchase | 2021-12-31 | 13G | ESSA PHARMA INC EPIX | EVENTIDE ASSET MANAGEMENT LLC | 3,318,647 7.500% | 983,479 (+42.12%) | Filing History |
| 2022-02-14 11:43 am Sale | 2021-12-31 | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | EVENTIDE ASSET MANAGEMENT LLC | 590,602 1.200% | -288,939 (-32.85%) | Filing History |
| 2022-02-14 11:41 am Purchase | 2021-12-31 | 13G | ZYMEWORKS INC ZYME | EVENTIDE ASSET MANAGEMENT LLC | 2,819,135 6.100% | 2,819,135 (New Position) | Filing History |
| 2022-02-14 11:39 am Purchase | 2021-12-31 | 13G | ANNEXON INC ANNX | EVENTIDE ASSET MANAGEMENT LLC | 2,850,000 7.400% | 845,384 (+42.17%) | Filing History |
| 2022-02-14 11:37 am Purchase | 2021-12-31 | 13G | VECTIVBIO HLDG AG VECT | EVENTIDE ASSET MANAGEMENT LLC | 2,339,044 6.700% | 2,339,044 (New Position) | Filing History |